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Dear Editor,
Epidemiologic evidence from the first large-scale studies suggests that males are more se-
verely affected than females by Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-CoV-2). 
They present worse outcomes, require longer hospitalization time and have a higher mortality 
rate when compared with women1. Scientists have speculated that female hormones, especially 
estrogen, could explain the better outcomes and the higher resistance to the virus observed in 
women. This higher resistance is due to the systemic and local effect of female hormones on the 
different cells. In particular, estrogens stimulate the immune system by modulating the function 
of B cells and improving T-helper 2 cell activity2. 
It is known that COVID-19 penetrates into the body through the upper respiratory tract, mu-
cosal contact, and eye conjunctiva through droplets in the air or deposited on surfaces spread 
by coughing or sneezing2. Estrogen has an established benefic effect on the upper and lower 
airways2. As first, women’s nose responds to the variation of estrogen levels by improving the lo-
cal immunity response as confirmed in several clinical trials3 and histology studies4. The hormone 
stimulates the reactivity of nasal mucosa3 (Figure 1) by determining turbinates hypertrophy and 
increased production of nasal mucus which contains mucins, electrolytes, IgA and IgG lysozyme, 
lactoferrin and oligosaccharides. These substances have anti-viral and antibacterial proprieties 
European Review for Medical and Pharmacological Sciences 2020; 24: 5195-5196
Gender differences in COVID-19 infection. 
The estrogen effect on upper and lower airways. 
Can it help to figure out a treatment?
Corresponding Author: Arianna Di Stadio MD, Ph.D; e-mail:  ariannadistadio@hotmail.com 
Arianna.distadio@unipg.it 
Figure 1. Schematics showing the protective action of estrogen in the upper and lower respiratory tract, and its benefit on the 
immune response.
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actions that are fundamental to contrast upper airway infections. In addition, estrogen stimu-
lates production of hyaluronic acid that maintains a good tropism of the nasal mucosa and nasal 
cilia3,4. Finally, estrogen stimulates the local nasal immune system acts directly on the nasal im-
mune system by increasing the activity of phagocytes, dendritic cells and natural killers3 (Figure 
1). These cells, once active, are able to destroy the virus preventing its diffusion into the lower 
respiratory tract or reduce the viral charge (virulence)3,4.
In addition to the local effects on nose filter, estrogen ensures good hydration of the mouth 
through the stimulation of hyaluronic acid production4, and improves the function of the lower 
respiratory tract by acting directly on the bronchial epithelia cells that increase the production 
of mucous rich in antiviral agents5,6. At this level the positive effect of estrogen is supported by 
the action of progesterone (PG) which upregulates the epidermal growth factor amphiregulin 
by inducing a repair of lung structure in case of viral infection; PG also improves the outcome of 
pulmonary disease5,6 when administered to women in menopause.
Although the role of estrogen is intriguing there are still open questions. Menopause causes 
a drastic drop of estrogen levels which might delete the risk difference between men and wom-
en; however, case series show that the gender difference is still present in the elderly. Children 
suffered less than adults from COVId_19 without gender differences; this could be related to 
the absence of androgen hormones prevalence on the estrogen hormone in male up to the 
complete sexual maturity. 
Based on this evidence, we hypothesize the potential utility of a local nasal spray with low-
dose isoflavones from soya (natural estrogen) suspended in a solution with sodium could stimu-
late nasal receptor by stopping or reducing the aggressiveness of COVID-19 as already suggested 
by a previous animal study7. 
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